Delivery Order SPE2DR25D3010-SPE2DR26F88EZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,385.52, represents a non-competitive, non-set-aside award and is set for completion by August 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for supply of ORGOVYX 120 MG tablets in quantities of 30s, valued at $6,927.60 with a firm fixed price structure and completion deadline of September 29, 2025. This delivery order represents a non-set-aside, competitively awarded procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This competitive, non-set-aside award carries a ceiling value of $4,156.56 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 20, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count packages) on September 22, 2025, with completion targeted for October 14, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a ceiling value of $8,760.78 and a firm fixed price structure. This delivery order, which represents a non-set-aside competitive award, is scheduled for completion by December 16, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $4,380.39 and an ultimate completion date of December 31, 2025. The contract involves no set-aside designation and represents a competitive award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded a delivery order valued at $4,380.39 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 MG tablets (30-count units) under a firm fixed-price contract. The award, issued on December 11, 2025, with an ultimate completion date of January 5, 2026, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at...
- The Defense Logistics Agency (DLA) awarded a $2,920.26 delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count) on December 3, 2025, with an ultimate completion date of December 24, 2025. This firm fixed-price contract represents a non-competitive set-aside award for pharmaceutical supply to support federal healthcare needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 12, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a contract ceiling value of $2,771.04 and completion targeted for April 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the awardee's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $8,313.12 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of ORGOVYX 120 mg tablets (30-count unit dose) with an ultimate completion date of October 16, 2025. The contract is non-competitive with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D3010Indefinite Delivery Contract
- SPE2DR25D3010-SPE2DR26F88EZDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This competitive, non-set-aside contract has a ceiling value of $1,460.13 and is scheduled for completion by January 2, 2026. The order is priced on a firm fixed-price basis and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical supply vehicle running through December 2026 that enables the company to provide pharmaceuticals and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's demonstrated capability to compete successfully for federal contracts, combined with its role as a prime vendor under the DLA's comprehensive pharmaceutical supply program, positions it to fulfill diverse medical supply requirements for military and veteran healthcare systems. This particular delivery order for ORGOVYX, a specialized pharmaceutical product, reflects the company's ongoing support of the Defense Health Agency and other government healthcare entities through flexible and responsive contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/9/25 |